Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Alicia F C OkinesTazia IrfanBernice AsareKabir MohammedPeter OsinAshutosh NerurkarIan E SmithMarina PartonAlistair RingStephen JohnstonNicholas C TurnerPublished in: Breast cancer research and treatment (2022)
ROLo (ClinicalTrials.gov Identifier: NCT03620643), ROSALINE (ClinicalTrials.gov Identifier: NCT04551495).
Keyphrases